influenza
viru
one
main
caus
acut
respiratori
infect
human
lead
annual
epidem
infrequ
pandem
two
influenza
pandem
centuri
asian
influenza
hong
kong
influenza
result
death
estim
million
peopl
global
today
descend
continu
caus
major
influenza
infect
human
far
learn
effect
antivir
drug
neuraminidas
na
inhibitor
target
na
glycoprotein
influenza
b
viru
releas
new
virion
infect
cell
key
step
influenza
life
cycl
need
neuraminidas
na
cleav
linkag
termin
sialic
acid
adjac
sugar
residu
na
inhibitor
design
prevent
key
step
block
activ
site
enzym
thu
allow
suffici
time
host
immun
system
remov
infect
virus
consist
effort
devot
develop
na
inhibitor
use
crystal
structur
subtyp
na
protein
inde
oseltamivir
tamiflu
repres
na
inhibitor
proven
uniqu
applic
oral
drug
clinic
practic
treatment
influenza
infect
howev
increas
medic
use
oseltamivirresist
strain
found
probabl
lead
larg
scale
outbreak
novel
pandem
flu
patchouli
alcohol
figur
well
known
centuri
major
constitu
pungent
oil
east
indian
shrub
pogostemon
cablin
blanco
benth
wide
use
fragranc
patchouli
oil
import
essenti
oil
perfum
industri
use
give
base
last
charact
fragranc
essenti
oil
appreci
characterist
pleasant
long
last
woodi
earthi
camphorac
odor
well
fix
properti
suitabl
use
soap
cosmet
product
aerial
part
pogostemon
cablin
wildli
use
treatment
common
cold
antifung
agent
china
moreov
plant
wide
use
tradit
chines
medicin
present
variou
type
pharmacolog
activ
accord
composit
oil
patchouli
alcohol
major
volatil
constitu
patchouli
oil
found
strongli
inhibit
replic
weakli
inhibit
replic
best
knowledg
antiinfluenza
viru
activ
patchouli
alcohol
evalu
yet
therefor
aim
present
studi
evalu
antiinfluenza
viru
activ
patchouli
alcohol
mtt
assay
mous
influenza
model
basi
explicitli
solvat
dock
molecular
dynam
md
method
appli
investig
bind
mode
involv
patchouli
alcohol
influenza
viru
na
protein
anticip
insight
understand
inhibit
mechan
valu
ration
design
novel
antiinfluenza
drug
first
efficaci
patchouli
alcohol
influenza
viru
replic
cell
viabil
examin
use
express
cytotox
patchouli
alcohol
mdck
patchouli
alcohol
mm
indic
patchouli
alcohol
affect
growth
mdck
tabl
thu
seem
antivir
effect
patchouli
alcohol
due
cytotox
moreov
patchouli
alcohol
found
inhibit
influenza
viru
base
valu
select
index
si
calcul
report
si
appropri
antivir
agent
suggest
patchouli
alcohol
judg
antiinfluenza
viru
activ
found
patchouli
alcohol
show
dosedepend
antiinfluenza
viru
activ
valu
furthermor
show
weak
activ
addit
inhibitori
activ
comprehens
view
antiinfluenza
activ
patchouli
alcohol
cell
pretreat
patchouli
alcohol
prior
viru
infect
pretreat
cell
virus
pretreat
prior
infect
pretreat
viru
patchouli
alcohol
ad
adsorpt
period
adsorpt
penetr
virus
cell
replic
experi
repeat
independ
three
time
data
present
averag
three
experi
symbol
indic
signific
differ
p
respect
mode
pretreat
viru
adsorpt
pretreat
cell
shown
figur
patchouli
alcohol
show
antiinfluenza
viru
activ
timedepend
manner
show
best
antivir
activ
ad
concentr
replic
period
inhibit
viral
replic
influenza
h
howev
signific
effect
detect
patchouli
alcohol
use
pretreat
cell
virus
patchouli
alcohol
ad
adsorpt
phase
result
suggest
inhibit
influenza
viru
patchouli
alcohol
appear
occur
much
strongli
penetr
viru
cell
besid
biochem
studi
indic
bioactiv
na
protein
essenti
determin
replic
influenza
viru
henc
conclud
function
na
protein
may
suppress
patchouli
alcohol
evalu
toxic
patchouli
alcohol
mean
valu
bodi
weight
mice
group
statist
analyz
mean
weight
mice
administ
mgkgdose
oseltamivir
mgkgdose
patchouli
alcohol
mgkgdose
patchouli
alcohol
one
time
daili
day
significantli
differ
compar
normal
control
mice
show
toxic
patchouli
alcohol
oseltamivir
within
test
concentr
p
physiolog
statu
observ
viru
infect
mice
three
day
viral
infect
mice
especi
mice
infect
control
group
show
chang
behavior
tendenc
huddl
diminish
vital
ruffl
fur
etc
mous
influenza
model
viral
infect
lead
loss
bodi
weight
high
mortal
therefor
efficaci
patchouli
alcohol
oseltamivir
evalu
basi
surviv
rate
measur
day
postinfect
treat
infect
anim
rel
untreat
infect
control
anim
comparison
efficaci
patchouli
alcohol
oseltamivir
vivo
mous
influenza
model
oral
treatment
show
dose
mgkgday
patchouli
alcohol
show
obviou
protect
influenza
viru
mean
day
death
detect
tabl
dose
lower
mgkgday
patchouli
alcohol
show
weaker
protect
measur
survivorstot
mgkgday
mean
day
death
wherea
oseltamivir
dose
level
mgkgday
show
protect
measur
survivorstot
influenza
viru
infect
control
group
survivor
view
vitro
vivo
data
conclud
patchouli
alcohol
could
use
treatment
human
influenza
viru
infect
base
experi
data
patchouli
alcohol
determin
bound
within
na
protein
total
energi
backbon
rootmeansquaredevi
rmsd
figur
indic
energyminim
patchouli
alcoholna
complex
equilibrium
sinc
ns
retain
quit
stabl
last
ns
consist
previou
md
result
na
inhibitor
accordingli
geometr
energet
analys
made
averag
structur
ns
md
trajectori
system
alreadi
equilibrium
interact
energi
einter
patchouli
alcohol
na
calcul
kcal
vdw
rather
electrostat
interact
found
play
domin
role
contribut
kcal
shown
figur
patchouli
alcohol
bound
activ
site
also
bound
oseltamivir
zanamivir
figur
show
oxygen
atom
patchouli
alcohol
orient
toward
sidechain
residu
one
hbond
form
residu
valu
distanc
figur
reveal
dock
complex
remain
rather
stabl
throughout
simul
averag
distanc
patchouli
alcohol
oh
patchouli
alcohol
less
sum
contribut
esum
residu
amount
kcal
respect
tabl
besid
patchouli
alcohol
stabil
residu
especi
residu
figur
tabl
matter
fact
residu
na
protein
alreadi
receiv
enough
attent
ration
drug
design
catalyt
residu
crucial
na
function
residu
import
stabil
na
activ
site
suggest
na
function
affect
presenc
patchouli
alcohol
consist
experi
patchouli
alcohol
match
na
activ
site
accept
interact
energi
consid
obviou
structur
discrep
current
na
inhibitor
repres
ideal
lead
compound
design
novel
antiinfluenza
agent
patchouli
alcohol
oseltamivir
obtain
sigma
chemic
co
st
loui
mo
usa
puriti
store
glass
vial
teflon
seal
cap
absenc
light
mdck
madindarbi
canin
kidney
purchas
harbin
veterinari
research
institut
harbin
heilongjiang
china
cell
grown
monolay
cultur
eagl
minimum
essenti
medium
emem
supplement
fetal
calf
serum
fc
uml
penicillin
streptomycin
monolay
remov
plastic
surfac
serial
passag
whenev
becam
confluent
cell
plate
onto
cultur
plate
cytotox
antiinfluenza
assay
propag
atmospher
influenza
strain
purchas
nation
control
institut
veterinari
bioproduct
pharmaceut
beij
china
viru
routin
grown
mdck
cell
stock
cultur
prepar
supernat
infect
cell
store
cellular
toxic
patchouli
alcohol
mdck
cell
assess
mtt
method
briefli
cell
seed
microtit
plate
absenc
presenc
variou
concentr
patchouli
alcohol
eight
replic
incub
humidifi
atmospher
h
supernat
discard
wash
pb
twice
mtt
reagent
mgml
pb
ad
well
incub
h
supernat
remov
dmso
ad
incub
anoth
min
plate
read
elisa
reader
thermo
molecular
devic
co
union
citi
usa
nm
mean
od
cell
control
well
assign
valu
maxim
nontox
concentr
cytotox
concentr
calcul
linear
regress
analysi
doserespons
curv
gener
data
inhibit
viru
replic
measur
mtt
method
serial
dilut
treat
viru
adsorb
cell
h
residu
inoculum
discar
infect
cell
ad
emem
contain
fc
assay
perform
eight
replic
incub
h
cultur
measur
mtt
method
describ
concentr
patchouli
alcohol
oseltamivir
inhibit
viru
number
determin
doserespons
curv
cell
virus
incub
patchouli
alcohol
differ
stage
viral
infect
cycl
order
determin
mode
antivir
action
cell
pretreat
patchouli
alcohol
viral
infect
virus
incub
patchouli
alcohol
infect
cell
virus
incub
togeth
patchouli
alcohol
adsorpt
penetr
viru
host
cell
patchouli
alcohol
alway
use
nontox
concentr
cell
monolay
pretreat
patchouli
alcohol
prior
inocul
viru
ad
patchouli
alcohol
cultur
medium
incub
h
compound
aspir
cell
wash
immedi
influenza
inoculum
ad
pretreat
viru
influenza
incub
medium
contain
patchouli
alcohol
room
temperatur
prior
infect
mdck
cell
analyz
antiinfluenza
inhibit
adsorpt
period
amount
influenza
mix
drug
ad
cell
immedi
h
adsorpt
inoculum
remov
dmem
supplement
fc
ad
cell
effect
patchouli
alcohol
influenza
also
test
replic
period
ad
adsorpt
typic
perform
antiinfluenza
suscept
studi
assay
run
eight
replic
kunm
mice
weigh
g
week
age
purchas
harbin
veterinari
research
institut
anim
co
ltd
harbin
heilongjiang
china
first
toxic
patchouli
alcohol
oseltamivir
assess
healthi
mice
loss
bodi
weight
compar
control
group
dmso
physiolog
salin
mice
oral
administ
mgkgdose
patchouli
alcohol
mgkgdose
patchouli
alcohol
mgkgdose
oseltamivir
dissolv
dmso
physiolog
salin
one
time
daili
day
weight
mice
determin
daili
conduct
procedur
accord
principl
laboratori
anim
care
nih
public
revis
guidelin
peke
univers
anim
research
committe
kunm
mice
anesthet
isofluran
expos
viru
intranas
instil
drug
prepar
dmso
physiolog
salin
administ
h
prior
viru
exposur
continu
daili
day
mice
observ
daili
chang
weight
death
paramet
evalu
antivir
activ
includ
weight
loss
reduct
mortal
andor
increas
mean
day
death
mdd
determin
day
subtyp
neuraminidas
crystal
structur
pdb
code
obtain
rcsb
protein
data
bank
conveni
structur
name
na
hereaft
geometri
partial
atom
charg
patchouli
alcohol
figur
calcul
discov
modul
insight
ii
appli
bfg
algorithm
consistentval
forcefield
cvff
converg
criterion
kcal
dock
molecular
dynam
md
simul
perform
gener
protocol
insight
ii
softwar
packag
consist
previou
literatur
md
simul
canon
ensembl
nvt
employ
normal
temperatur
k
md
temperatur
control
veloc
scale
thermostat
integr
classic
equat
motion
achiev
use
verlet
algorithm
system
solvat
larg
sphere
water
molecul
radiu
enough
hold
ensembl
md
trajectori
gener
use
time
step
total
ns
save
interv
interact
energi
patchouli
alcohol
na
respect
residu
na
activ
site
calcul
dock
modul
ns
md
trajectori
result
express
mean
valu
standard
deviat
sd
n
signific
differ
calcul
oneway
analysi
varianc
valu
p
consid
signific
conclus
patchouli
alcohol
possess
antiinfluenza
viru
activ
via
interfer
na
function
cleav
bond
sialic
acid
glycoconjug
result
provid
promis
inform
potenti
use
patchouli
alcohol
treatment
influenza
viru
infecti
diseas
mechanist
studi
antiinfluenza
viru
activ
need
support
point
view
